Item 1. Business,” “Item 3. Legal Proceedings” and “Item 6.
Management’s Discussion and Analysis or Plan of Operation”, constitute
“forward-looking statements” within the meaning of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”), and Section 21E of the
Securities Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995 (collectively, the “Reform Act”). Certain, but not
necessarily all, of such forward-looking statements can be identified by the
use
of forward-looking terminology such as “believes,” “expects,” “may,” “will,”
“should,” or “anticipates” or the negative thereof or other variations thereon
or comparable terminology, or by discussions of strategy that involve risks
and
uncertainties. All statements other than statements of historical fact included
in this Form 10-KSB regarding our financial position, business strategy and
plans or objectives for future operations are forward-looking statements.
Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors which may cause the actual results, performance or achievements
to
be materially different from any future results, performance or achievements
expressed or implied by such forward-looking statements and other factors
referenced in this Form 10-KSB. We do not undertake and specifically decline
any
obligation to publicly release the results of any revisions which may be made
to
any forward-looking statement to reflect events or circumstances after the
date
of such statements or to reflect the occurrence of anticipated or unanticipated
events.
RISK
FACTORS
An
investment in our common stock involves a high degree of risk. You should
carefully consider the following material risks, before you decide to buy our
common stock. If any of the following risks actually occur, our business,
results of operations and financial condition would likely suffer. In these
circumstances, the market price of our common stock could decline and you may
lose all or part of your investment.
WE
HAD A CURRENT ACCUMULATED DEFICIT OF $20,740,063 AS OF MARCH 31, 2008 AND IF
WE
CONTINUE TO INCUR OPERATING LOSSES, WE MAY BE UNABLE TO SUPPORT OUR BUSINESS
PLAN, WHICH WILL HAVE A DETRIMENTAL EFFECT ON OUR STOCK.
We
have incurred losses in each of our last three fiscal years. As of March 31,
2008, we had an accumulated deficit of $20,740,063. If we continue to incur
operating losses and fail to become a profitable company, we may be unable
to
support our business plan, namely to market our K-Line of Chemical Products
for
the oil and gas industry, and the Green Globe Chemical Products. We incurred
net
losses from continuing operations of $2,040,390 and $2,272,791 in the fiscal
years ended March 31, 2008 and 2007, respectively. Our future profitability
depends in large part on our ability to market and support our Specialty
Chemical Products which we derive the majority of our revenues. We cannot assure
you that we will achieve or sustain significant sales or profitability in the
future.
WE
ARE DEPENDENT ON OUR ABILITY TO RAISE CAPITAL FROM EXTERNAL FUNDING SOURCES.
IF
WE ARE UNABLE TO CONTINUE TO OBTAIN NECESSARY CAPITAL FROM OUTSIDE SOURCES,
WE
WILL BE FORCED TO REDUCE OR CURTAIL OPERATIONS.
We
have
limited financial resources. As a result we need to obtain additional capital
from outside sources to continue operations and commercialize our business
plan.
We cannot assure that adequate additional funding will be available. If we
are
unable to continue to obtain needed capital from outside sources, we will be
forced to reduce or curtain our operations.
Our
ability to execute our business plan depends upon our ability to obtain
financing through
|
·
|
bank
or other debt financing,
|
|
·
|
equity
financing,
|
|
·
|
strategic
relationships and/or
|
|
·
|
other
means.
|
OUR
INDEPENDENT AUDITORS HAVE EXPRESSED THAT THERE IS SUBSTANTIAL DOUBT ABOUT OUR
ABILITY TO CONTINUE AS A GOING CONCERN.
Our
independent auditors issued an explanatory paragraph expressing substantial
doubt about our ability to continue as a going concern on our financial
statements for fiscal 2008, based on the significant operating losses and a
lack
of external financing. Neither our March 31, 2008 nor March 31, 2007 financial
statements include any adjustments that resulted from the outcome of this
uncertainty. Our inability to continue as a going concern would require a
restatement of assets and liabilities on a liquidation basis, which would differ
materially and adversely from the going concern basis on which our consolidated
financial statements have been prepared.
THERE
ARE SIGNIFICANT OBSTACLES TO ENTERING THE OIL AND GAS PRODUCING INDUSTRY THAT
HAVE CONTRIBUTED TO THE SLOW PACE AT WHICH OUR K-LINE OF CHEMICAL PRODUCTS
ARE
BEING INTRODUCED TO THE MARKET.
Our
business plan is focused largely on marketing efforts for our K-Line of Chemical
Products for the oil and gas industry. Although we believe that the application
of our K-Line of Chemical Products for the oil and gas industry on a continuous
basis will result in higher production and lower power lease operating costs,
the introduction of our K-Line of Chemical Products into the oil and gas
producing industry has been extremely difficult. Many entrenched players such
as
the “hot oilers” and the major oil service companies that benefit from high
markups on their proprietary products have no incentive to promote the use
of
our chemical products. Moreover, oil production engineers are extremely
reluctant to risk damage to a well from a product that does not have the
endorsement of a major enterprise. Consequently, the pace of introduction of
our
K-Line of Chemical Products has been much slower than we initially anticipated.
If we and our K-Line of Chemical Products marketing partners are unable to
successfully achieve market acceptance our products, our future results of
operations and financial condition will be adversely affected.
THE
SUCCESS OF OUR K-LINE OF CHEMICAL PRODUCTS WILL BE HIGHLY DEPENDENT UPON THE
LEVEL OF ACTIVITY AND EXPENDITURES IN THE OIL AND NATURAL GAS INDUSTRIES AND
A
DECREASE IN THE LEVELS THEREOF WOULD, IN ALL LIKELIHOOD, ADVERSELY IMPACT SALES
OF OUR K-LINE OF CHEMICAL PRODUCTS.
We
anticipate that demand for our oil and gas-cleaning product will depend on
the
levels of activity and expenditures in the industry, which are directly affected
by trends in oil and natural gas prices. We anticipate that demand for our
K-Line of Chemical Product sales will be particularly sensitive to the level
of
development, production and exploration activity of, and corresponding capital
spending by, oil and natural gas companies. Prices for oil and gas are subject
to large fluctuations in response to relatively minor changes in the supply
of
and demand for oil and gas, market uncertainty, political stability and a
variety of other factors that are beyond our control. Any prolonged reduction
in
oil and natural gas prices will depress the level of exploration, and
development and production activity. Lower levels of activity are expected
to
result in a corresponding decline in the demand for our oil and gas well
products, which could have an adverse impact on our prospects, results of
operations and financial condition. Factors affecting the prices of oil and
natural gas include:
| • |
worldwide
political, military and economic conditions, including the ability
of OPEC
(the Organization of Petroleum Exporting Countries) to set and maintain
production levels and prices for oil and
gas;
|
| • |
overall
levels of global economic growth and
activity;
|
| • |
global
weather conditions;
|
| • |
the
level of production by non-OPEC
countries;
|
| • |
the
policies of governments regarding the exploration for and production
and
development of their oil and natural gas reserves;
and
|
| • |
actual
and perceived changes in the supply of and demand for oil and natural
gas.
|
WE
MAY NOT BE ABLE TO GENERATE SUBSTANTIAL REVENUES FROM OUR GREEN GLOBE CHEMICAL
PRODUCTS.
Our
sales to date have been substantially dependent on sales of our K-Line of
Chemical Products. Sales of Green Globe Chemical Products accounted for
approximately 27% of revenues for the fiscal year ended March 31, 2008. The
U.S.
military represented approximately 90% of such revenues from the sales of our
Green Globe Chemical Products for the fiscal year ended March 31, 2008. If
we
fail to develop significant revenue from Green Globe Chemical Products or the
U.S. military ceases or decreases its use of our Green Globe Chemical Products,
our business plan and financial condition will be adversely
affected.
IF
OUR STRATEGIC PARTNERS DO NOT EFFECTIVELY MARKET OUR PRODUCTS, WE WILL NOT
GENERATE SIGNIFICANT SALES OR PROFITS AND WE DO NOT CURRENTLY HAVE THE INTERNAL
RESOURCES TO MARKET OUR PRODUCTS DIRECTLY.
We
utilize third parties to assist in marketing, selling and distributing our
products. We believe that the establishment of a network of third party
strategic partners, particularly abroad, with extensive and specific knowledge
of the various applications in the oil and gas industry is important for our
success. We cannot assure you that our current or future strategic partners
will
purchase our products at sufficient levels or provide us with adequate support.
If one or more of our partners underperforms or if any of our strategic
relationships are terminated or otherwise disrupted, our operating performance,
results of operations and financial condition will be adversely
affected.
WE
DEPEND ON A SMALL NUMBER OF CUSTOMERS FOR A SUBSTANTIAL PORTION OF OUR REVENUES,
BUT WE HAVE NO LONG TERM CONTRACTS OR BINDING PURCHASE COMMITMENTS FROM THESE
CUSTOMERS.
We
currently have a limited number of recurring customers for our products, none
of
whom have entered into long-term contracts or binding purchase commitments
with
us. Our three largest customers accounted for 71% and 64% of our revenues for
the fiscal years ended March 31, 2008 and 2007, respectively.
WE
RELY ON THIRD PARTIES FOR THE RAW MATERIALS NECESSARY TO MAKE OUR PRODUCTS,
LEAVING US POTENTIALLY VULNERABLE TO SUBSTANTIAL COST INCREASES AND
DELAYS.
All
of the raw materials necessary for the manufacture of our products are generally
available from multiple sources. We have negotiated favorable arrangements
with
our current suppliers. If one or more of our current suppliers were no longer
able to supply the raw materials that we need, we would be required to negotiate
arrangements with alternate suppliers, which would likely include some cost
or
delay and could be substantial. In addition, no assurance can be given that
any
alternative arrangements that we secure would be on terms as favorable as our
current arrangements.
WE
DEPEND ON INDEPENDENT MANUFACTURERS OF OUR PRODUCTS; ANY PROLONGED INTERRUPTION
IN THEIR BUSINESS COULD CAUSE US TO LOSE OUR CUSTOMERS.
We
do not own any manufacturing facilities. Our chemical products are generally
manufactured by contract blenders at a number of different facilities. Chemical
blenders are relatively easy to replace. While we believe these facilities
have
the capacity to meet our current production needs and also meet applicable
environmental regulations, we cannot be certain that these facilities will
continue to meet our needs or continue to comply with environmental laws. In
addition, these facilities are subject to certain risks of damage, including
fire, which would disrupt production of our products. To the extent we are
forced to find alternate facilities, it would likely involve delays in
manufacturing and potentially significant costs.
The
chemical blender and independent coater that manufactures our products are
bound
by confidentiality agreements that obligate them not to disclose or use our
proprietary information. A breach of one or more of these agreements could
have
a detrimental effect on our business and prospects.
ENVIRONMENTAL
PROBLEMS AND LIABILITIES COULD ARISE AND BE COSTLY FOR US TO CLEAN
UP.
We
are subject to various foreign, federal, state and local laws and regulations
relating to the protection of the environment, including the Industrial Site
Recovery Act, a New Jersey statute requiring clearance by the state prior to
the
sale of any industrial facility. These laws provide for retroactive strict
liability for damages to natural resources or threats to public health and
safety, rendering a party liable without regard to its negligence or fault.
Sanctions for noncompliance may include revocation of permits, corrective action
orders, and administrative or civil penalties or even criminal prosecution.
We
have not, to date, incurred any serious liabilities under environmental
regulations and believe that we are in substantial compliance therewith.
Nevertheless, we cannot be certain that we will not encounter environmental
problems or incur environmental liabilities in the future that could adversely
affect our business.
BECAUSE
WE ARE SMALLER AND HAVE FEWER FINANCIAL AND MARKETING RESOURCES THAN MANY OF
OUR
COMPETITORS, WE MAY NOT BE ABLE TO SUCCESSFULLY COMPETE IN THE EXTREMELY
COMPETITIVE CHEMICAL INDUSTRIES.
We
compete directly or indirectly with other producers of specialty chemical
products, most of which are or have aligned themselves with more established
companies, have greater brand recognition and greater financial and marketing
resources. Generally, we attempt to compete by offering what we hope to be
lower
prices and better service. However, the prices for our K-Line of Chemical
Products and Green Globe Chemical Products are higher than competing products;
therefore, we attempt to compete by emphasizing product effectiveness and
environmental safety.
WE
MAY NOT BE ABLE TO RETAIN OUR EXECUTIVE OFFICERS WHO WE NEED TO SUCCEED, AND
ADDITIONAL QUALIFIED PERSONNEL ARE EXTREMELY DIFFICULT TO
ATTRACT.
Our
performance depends, to a significant extent, upon the efforts and abilities
of
our executive officers. We do not have employment agreements with certain of
our
executive officers and do not maintain any key man insurance on their lives
for
our benefit. The loss of the services of our executive officers could have
a
serious and adverse effect on our business, financial condition and results
of
operations. Our success will also depend upon our ability to recruit and retain
additional qualified senior management personnel. Competition is intense for
highly skilled personnel in our industry and, accordingly, no assurance can
be
given that we will be able to hire or retain sufficient personnel.
OUR
MANAGEMENT OWNS A SUBSTANTIAL AMOUNT OF OUR STOCK AND IS CAPABLE OF INFLUENCING
OUR BUSINESS AND AFFAIRS.
Our
directors and executive officers beneficially own approximately 30.1% of our
outstanding common stock. As such, they will be able to significantly influence
the election of the members of our board of directors and the outcome of
corporate actions that require shareholder approval, such as mergers and
acquisitions. In addition, Pursuant to the terms of the Company’s Series A
Convertible Preferred Stock (the “Preferred Stock”) and an agreement with
Sherleigh Associates Profit Sharing Plan (“Sherleigh”), as holder of all of the
outstanding shares of Preferred Stock, Sherleigh has the right to designate
a
majority of the members of our board of directors. Jack Silver, one of our
directors, as the trustee of Sherleigh, has voting control over the shares
of
Preferred Stock held by Sherleigh. The level of ownership by our directors
and
executive officers, together with particular provisions of our articles of
incorporation, bylaws and Nevada law, may have a significant effect in delaying,
deferring or preventing any change in control and may adversely affect the
voting and other rights of our other shareholders.
IF
WE
CANNOT PROTECT OUR PROPRIETARY RIGHTS AND TRADE SECRETS OR IF WE WERE FOUND
TO
BE INFRINGING ON THE PROPRIETARY RIGHTS OF OTHERS, OUR BUSINESS WOULD BE
SUBSTANTIALLY HARMED.
Our
success depends in large part on our ability to protect the proprietary nature
of our products, preserve our trade secrets and operate without infringing
the
proprietary rights of third parties. If other companies obtain and copy our
technology or claim that we are making unauthorized use of their proprietary
technology, we may become involved in lengthy and costly disputes. If we are
found to be infringing on the proprietary rights of others, we could be required
to seek licenses to use the necessary technology. We cannot assure you that
we
could obtain these licenses on acceptable terms, if at all. In addition, the
laws of some foreign countries may not provide adequate protection for our
proprietary technology.
To
protect our intellectual property, we seek patents and enter into
confidentiality agreements with our employees, manufacturers and marketing
and
distribution partners. We cannot assure you that our patent applications will
result in the successful issuance of patents or that any issued patents will
provide significant protection for our technology and products. In addition,
we
cannot assure you that other companies will not independently develop competing
technologies that are not covered by our patents. There is also no assurance
that confidentiality agreements will provide adequate protection of our trade
secrets, know-how or other proprietary information. Any unauthorized disclosure
and use of our proprietary technology, whether in breach of an agreement or
not,
could have an adverse effect on our business, prospects, results of operations
and financial condition.
THE
PUBLIC MARKET FOR OUR COMMON STOCK HAS BEEN CHARACTERIZED BY A LOW VOLUME OF
TRADING AND OUR STOCKHOLDERS MAY NOT BE ABLE TO RESELL THEIR SHARES AT OR ABOVE
THE PRICE AT WHICH THEY PURCHASED THEIR SHARES, IF AT ALL.
Historically,
the volume of trading in our common stock has been low. A more active public
market for our common stock may not develop or, even if it does in fact develop,
may not be sustainable. The market price of our common stock may fluctuate
significantly in response to factors, some of which are beyond our control.
These factors include:
| • |
product
liability claims and other
litigation;
|
| • |
the
announcement of new products or product enhancements by us or our
competitors;
|
| • |
developments
concerning intellectual property rights and regulatory
approvals;
|
| • |
quarterly
variations in our competitors’ results of
operations;
|
| • |
developments
in our industry; and
|
| • |
general
market conditions and other factors, including factors unrelated
to our
own operating performance.
|
Recently,
the stock market in general has experienced extreme price and volume
fluctuations. In particular, market prices of securities of specialty chemical
products companies have experienced fluctuations that are often unrelated to
or
disproportionate from the operating results of these companies. Continued market
fluctuations could result in extreme volatility in the price of shares of our
common stock, which could cause a decline in the value of our shares. Price
volatility may be worse if the trading volume of our common stock is
low.
WE
HAVE OUTSTANDING WARRANTS AND OPTIONS, AND WE ARE ABLE TO ISSUE “BLANK CHECK”
PREFERRED STOCK, THAT COULD BE ISSUED RESULTING IN THE DILUTION OF COMMON STOCK
OWNERSHIP.
As
of
June 30, 2008, we had outstanding Preferred Stock, warrants and options that,
when exercised and converted, could result in the issuance of up to 11,802,500
additional shares of common stock. In addition, our Articles of Incorporation
allow the board of directors to issue up to 100,000 shares of preferred stock
and to fix the rights, privileges and preferences of those shares without any
further vote or action by the shareholders. We currently have 3 shares of
Preferred Stock outstanding. To the extent that outstanding warrants, options
and preferred stock or similar instruments or convertible preferred stock issued
in the future are exercised or converted, these shares will represent a dilution
to the existing shareholders. The preferred stock could hold dividend
priority and a liquidation preference over shares of our common
stock. Thus, the rights of the holders of common stock are and will
be subject to, and may be adversely affected by, the rights of the holders
of
any preferred stock. Any such issuance could be used to discourage an
unsolicited acquisition proposal by a third party.
OUR
COMMON STOCK IS CONSIDERED A “PENNY STOCK” AND MAY BE DIFFICULT TO SELL WHEN
DESIRED.
The
SEC has adopted regulations that define a “penny stock”, generally, to be an
equity security that has a market price of less than $5.00 per share or an
exercise price of less than $5.00 per share, subject to specific exemptions.
The
market price of our common stock has been less than $5.00 per share. This
designation requires any broker or dealer selling our securities to disclose
certain information concerning the transaction, obtain a written agreement
from
the purchaser and determine that the purchaser is reasonably suitable to
purchase the securities. These rules may restrict the ability of brokers or
dealers to sell our common stock and may affect the ability of stockholders
to
sell their shares. In addition, since our common stock is currently quoted
on
the OTC Bulletin Board, stockholders may find it difficult to obtain accurate
quotations of our common stock, may experience a lack of buyers to purchase
our
shares or a lack of market makers to support the stock price.
A
SIGNIFICANT NUMBER OF OUR SHARES ARE ELIGIBLE FOR SALE AND THEIR SALE OR
POTENTIAL SALE WILL PROBABLY DEPRESS THE MARKET PRICE OF OUR
STOCK.
Sales
of a significant number of shares of our common stock in the public market
could
harm the market price of our common stock. Some or all of the shares of our
common stock may be offered from time to time in the open market without
registration pursuant to Rule 144, and these sales could have a depressive
effect on the market for our common stock.
WE
DO
NOT ANTICIPATE PAYING DIVIDENDS ON OUR COMMON STOCK IN THE FORESEEABLE FUTURE;
THEREFORE, YOU SHOULD NOT BUY THIS STOCK IF YOU WISH TO RECEIVE CASH
DIVIDENDS.
We
currently intend to retain our future earnings in order to support operations
and finance expansion; therefore, we do not anticipate paying any cash dividends
on our common stock in the foreseeable future.
ITEM
7. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The
response to this item is submitted as a separate section of this Report
beginning on page F-1.
ITEM
8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
None
ITEM
8A. CONTROLS AND PROCEDURES
Evaluation
of the Company's Disclosure Controls and Procedures
We
carried out an evaluation, under the supervision and with the participation
of
the Company's management, including our Chief Executive Officer and our
Principal Accounting Officer (Interim Chief Financial Officer), of the
effectiveness of our “disclosure controls and procedures” (as defined in Rules
13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended)as
of
March 31, 2008. Based upon that evaluation, the Chief Executive Officer and
the
Principal Accounting Officer (Interim Chief Financial Officer) concluded that
our disclosure controls and procedures are effective, in all material respects,
with respect to the recording, processing, summarizing, and reporting, within
the time periods specified in the Securities and Exchange Commission's rules
and
forms, of information required to be disclosed by us in the reports that we
file
or submit under the Exchange Act. In designing and evaluating our “disclosure
controls and procedures” (as defined in Rules 13a-15(e) or 15d-15(e) of the
Securities Exchange Act of 1934, as amended), management recognized that any
controls and procedures, no matter how well designed and operated, can provide
only reasonable assurances of achieving the desired control objectives, as
ours
are designed to do, and management necessarily was required to apply its
judgment in evaluating the cost-benefit relationship of possible controls and
procedures.
Management’s
Annual Report on Internal Control Over Financial Reporting
Our
management is responsible for establishing and maintaining adequate internal
control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f)
of
the Securities Exchange Act of 1934, as amended. Internal control over financial
reporting is designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation and fair presentation of financial
statements for external purposes, in accordance with generally accepted
accounting principles. The effectiveness of any system of internal control
over
financial reporting is subject to inherent limitations and therefore, may not
prevent or detect misstatements. Also, projections of any evaluation of
effectiveness of future periods are subject to the risk that the controls may
become inadequate due to change in conditions, or that the degree of compliance
with the policies or procedures may deteriorate.
Our
management conducted an evaluation of the effectiveness of internal control
over
financial reporting using the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission. Based on this evaluation, our
management concluded that as of March 31, 2008, our internal control over
financial reporting was not effective. Specifically, the Company’s management
and its auditors determined that a material weakness existed in our internal
control over financial reporting. The material weakness relates to the lack
of
segregation of duties in financial reporting, as our financial reporting and
all
accounting functions are performed by our Interim Chief Financial Officer.
Due
to our lack of funds, the Company has an insufficient number of personnel having
adequate knowledge, experience and training, and the Company does not anticipate
having the ability to retain such qualified personnel until it is able to obtain
adequate funding.
This
annual report does not include an attestation report of the Company’s registered
public accounting firm regarding internal control over financial reporting.
Management’s report was not subject to attestation by the Company’s registered
public accounting firm pursuant to temporary rules of the Securities and
Exchange Commission that permit the Company to provide only management’s report
in this annual report.
Changes
in Control Over Financial Reporting
Management
has not identified any change in our internal control over financial reporting
that occurred during the fourth quarter of the fiscal year ended March 31,
2008
that has materially affected, or is reasonably likely to materially affect,
the
Company’s internal control over financial
reporting.
ITEM
8B. OTHER INFORMATION
None
PART
III
ITEM
9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS, CONTROL PERSONS AND CORPORATE
GOVERNANCE; COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE
ACT.
The
following table shows the positions held by our board of directors and executive
officers and their ages as of June 30, 2008.
|
Name
|
Age
|
Position
|
||
|
Ronald
Wilen
|
|
Director,
Chief Executive Officer, President and Secretary
|
||
|
Jack
Silver
|
|
Director
and Chairman of the Board
|
||
|
James
McKeever, CPA
|
|
Interim
Chief Financial Officer
|
||
|
Adam
Hershey
|
|
Director
|
||
|
Peter
Garson-Rappaport
|
|
Director
|
||
|
Martin
Rappaport
|
|
Director
|
||
|
John
A. Lack
|
|
Director
|
The
principal occupations for the past five years (and, in some instances, for
prior
years) of each of our executive officers and directors are as
follows:
Ronald
Wilen.
Mr.
Wilen has served as a member of our board since October 1995, our Chief
Executive Officer since November 2007, and Secretary since May 2006.
Mr. Wilen also served as our Chief Executive Officer from October 1995 to
September 2004, our President from October 1995 to August 2001, our Executive
Vice President of Research and Development from October 1995 to November 2007
and as our Chairman of the Board from August 2001 to January 2008.
Jack
Silver. Mr.
Silver has served as a member of the Board as its Chairman since January 2008.
Mr. Silver is the principal investor and manager of SIAR Capital, LLC, an
independent investment fund that invests primarily in undervalued, emerging
growth companies, and is the trustee of Sherleigh.
James
McKeever, CPA.
Mr.
McKeever has been our Interim Chief Financial Officer since January 2004. He
also continues to be a partner in the accounting firm of Abrams & McKeever
CPA’s, which he joined in January 2000. Mr. McKeever has more than 18 years’
experience in public accounting and financial reporting, and is a member of
the
New Jersey Society of Certified Public Accountants.
Adam
Hershey.
Mr.
Hershey has served as a member of the Board since January 2008. Mr. Hershey
has
been a partner at SIAR Capital, LLC since September 2007. From March 2005 until
joining SIAR, Mr. Hershey was a Vice President and Portfolio Manager of
Neuberger Berman, LLC, a subsidiary of Lehman Brothers, managing capital for
institutions and high net worth individuals. From 2003 to March 2005, Mr.
Hershey was a Partner and Portfolio Manager at Sloate, Weisman, Murray &
Company, a registered investment advisor that was acquired by Neuberger Berman,
LLC in March 2005.
Peter
Garson-Rappaport.
Mr.
Rappaport is an analyst at SIAR Capital, LLC. He has been at SIAR since December
2006. He previously was a co-owner and manager of Wash U Wash, a third party
provider of laundry and dry-cleaning services. He also served as deputy finance
director of Jeff Smith for Congress Campaign in the spring of 2004.
Martin
Rappaport.
Mr.
Rappaport has served as a member of our board since June 2001. Mr. Rappaport
is
self-employed. For more than 30 years, he has developed and managed commercial
and residential real estate. Mr. Rappaport is an active supporter and
contributor to Blythedale Children’s Hospital in Valhalla, New
York.
John
A. Lack. Mr.
Lack
has served as a member of our board since June 2008. Since 1998, Mr. Lack has
been the managing general partner of Digitar, a media investment and consulting
company. In his 35-year career in the media and entertainment industries, Mr.
Lack is best known for creating MTV. Most recently Mr. Lack was a founding
partner & CEO of Firebrand, the first multi-platform network dedicated to
commercial culture. Mr. Lack is also the Chairman of the Guardian’s Council at
the Pollock-Krasner House and Study Center in East Hampton, NY and Chairman
of
the ASGOG Foundation.
Directors
are elected annually and serve until the next annual meeting of the Company’s
stockholders, and until their successors have been elected and have qualified.
Officers are appointed to their positions, and continue in such positions,
at
the discretion of the directors.
Committees
of the Board
The
Board
of Directors is the acting Audit Committee. Our Board of Directors has
determined that there is no person on our Board of Directors who qualifies
as an
audit committee financial expert as that term is defined by applicable
Securities and Exchange Commission rules. The Board of Directors believes that
obtaining the services of an audit committee financial expert is not
economically rational at this time in light of the costs associated with
identifying and retaining an individual who would qualify as an audit committee
financial expert.
Indebtedness
of Executive Officers
and Directors
No
executive officer, director or any member of these individuals’ immediate
families or any corporation or organization with whom any of these individuals
is an affiliate is or has been indebted to us since the beginning of our last
fiscal year.
Family
Relationships
There
are
no family relationships among our executive officers and directors.
Legal
Proceedings
During
the past five years, none of our executive officers, directors, promoters or
control persons has been involved in a legal proceeding material to an
evaluation of the ability or integrity of such person.
Compliance
with Section 16(a) of the Securities Exchange Act of 1934
Section
16(a) of the Securities Act of 1934, as amended, requires our directors and
executive officers, and persons who own more than 10% our outstanding common
stock, to file with the SEC, initial reports of ownership and reports of changes
in ownership of our equity securities. These persons are required by SEC
regulations to furnish us with copies of all the reports they file.
To
our
knowledge, based solely on a review of the copies of the reports furnished
to us
and written or oral representations that no other reports were required for
those persons during the fiscal year ended March 31, 2008, we believe that
all
of our officers, directors and greater than 10% beneficial owners complied
with
the reporting requirements of Section 16(a) of the Securities Exchange Act
of
1934, as amended, other than as follows:
| • |
Ronald
Wilen, a director and our chief executive officer and president,
Martin
Rappaport, a director, Louis Bernstein, a former director, and Andrea
Pampanini, a former director, each failed to report the granting
of
options for 10,000 shares of our common stock in lieu of an annual
director retainer and meeting fees.
|
| • |
Adam
Hershey and Peter Garson-Rappaport, both directors, failed to file
a Form
3 indicating that they did not beneficially own any securities of
the
Company as of the date they each became a
director.
|
Code
of Ethics
We
have
adopted a Code of Business Conduct and Ethics (the “Code”) that applies to all
of our employees (including executive officers) and directors. The Code is
available on our website at www.unitedenergycorp.net under the heading
“Investor Information”. We intend to satisfy the disclosure requirement
regarding any waiver of a provision of the Code applicable to any executive
officer or director, by posting such information on such website.
ITEM
10. EXECUTIVE COMPENSATION
The
following Summary Compensation Table sets forth, for the years indicated, all
cash compensation paid, distributed or accrued for services, including salary
and bonus amounts, rendered in all capacities by our Chief Executive Officer
and
all other executive officers who received or are entitled to receive
remuneration in excess of $100,000 during the stated periods.
|
|
Summary Compensation Table
|
|||||||||||||||
|
Name
and
Principal
Position
|
Fiscal
Year
|
Salary
|
Option Awards
|
All other
Compensation
|
Total
|
|||||||||||
|
|
|
($)
|
($)
|
($)
|
(1) |
($)
|
||||||||||
|
Ronald
Wilen
|
2008
|
200,769
|
98,700
|
7,935
|
(2)
|
307,404
|
||||||||||
|
Chief
Executive Officer and President
|
2007
|
200,000
|
3,875
|
8,901
|
(2)
|
212,776
|
||||||||||
|
|
||||||||||||||||
|
Brian
King (3)
|
2008
|
130,769
|
(4)
|
-
|
11,088
|
(3)
|
141,857
|
|||||||||
|
Former
President and Chief Executive Officer
|
2007
|
200,000
|
495,000
|
17,067
|
(3)
|
712,067
|
||||||||||
| (1) |
We
pay for medical insurance for all employees. Included in the table
is the
amount of the premiums paid by us dependent on the coverage
provided.
|
| (2) |
During
the fiscal years ended March 31, 2008 and 2007, we paid for the lease
on
one automobile used by Mr. Wilen under monthly lease payments. We
also
paid for medical insurance for Mr. Wilen at a rate of $325.80 per
month.
|
| (3) |
We
paid for Mr. King’s medical insurance at a |